Kamada (KMDA) FCF Payout Ratio Growth (5y) (2018 - 2026)
Kamada (KMDA) FCF Payout Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.16% |
| Dec 31, 2025 | 32.22% |
| Sep 30, 2025 | -17.71% |
| Jun 30, 2025 | -17.44% |
| Dec 31, 2024 | -13.85% |
| Sep 30, 2024 | -5.96% |
| Jun 30, 2024 | 0.16% |
| Dec 31, 2023 | 16.68% |
| Sep 30, 2023 | 19.41% |
| Jun 30, 2023 | 17.03% |
| Mar 31, 2023 | -47.98% |
| Sep 30, 2022 | -6.76% |
| Jun 30, 2022 | 1.39% |
| Mar 31, 2022 | -9.92% |
| Sep 30, 2021 | -38.52% |
| Jun 30, 2021 | -110.40% |
| Sep 30, 2020 | 89.88% |
| Jun 30, 2020 | 45.46% |
| Sep 30, 2019 | 23.63% |
| Jun 30, 2019 | 20.05% |